id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
ajst-32484	Gao, Ziyuan; Chen, Yuzhu	Research Progress on Resistance Mechanisms and Post-Resistance Treatment of Targeted Therapy in Non-Small Cell Lung Cancer	2025	8	.pdf	application/pdf	3534	274	56	[27] Odogwu, L., et al., FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations. [6] Yun, C.H., et al., The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.	cache/ajst-32484.pdf	txt/ajst-32484.txt